Scarica l'app Stockscreener
49.53
7.72%
3.55
Pre-mercato:
49.69
0.16
+0.32%
Precedente Chiudi:
$45.98
Aprire:
$47.77
Volume 24 ore:
6.51M
Relative Volume:
1.22
Capitalizzazione di mercato:
$8.89B
Reddito:
$1.27B
Utile/perdita netta:
$-245.03M
Rapporto P/E:
-35.20
EPS:
-1.4071
Flusso di cassa netto:
$-245.36M
1 W Prestazione:
+5.80%
1M Prestazione:
-0.90%
6M Prestazione:
-44.89%
1 anno Prestazione:
+14.84%
Intervallo 1D:
$47.62
$49.60
Intervallo di 1 settimana:
$42.41
$50.81
Portata 52W:
$39.01
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Tempus AI jumps as investors focus on new “Active Follow-Up” workflow and Needham conference visibility - Quiver Quantitative
Tempus Announces 31 Abstracts for AACR 2026 - National Today
Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz - Benzinga
Tempus AI (TEM) Announces Acceptance of 31 Abstracts for AACR An - GuruFocus
Promising Artificial Intelligence Stocks To Watch NowApril 14th - MarketBeat
Why Tempus AI Stock Is Quietly Climbing Higher - TipRanks
Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration - MSN
Cancer meeting picks 31 Tempus studies, including an oral session - Stock Titan
Tempus AI, Inc. Launches Automated Active Follow-Up Service - marketscreener.com
Mizuho Securities Initiates Tempus AI(TEM.US) With Buy Rating, Announces Target Price $100 - Moomoo
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care - 01net
Tempus AI (NASDAQ:TEM) Upgraded at TD Cowen - MarketBeat
Jefferies Financial Group Begins Coverage on Tempus AI (NASDAQ:TEM) - MarketBeat
TD Cowen Upgrades Tempus AI(TEM.US) to Buy Rating, Cuts Target Price to $65 - Moomoo
TD Cowen upgrades Tempus AI stock rating on stronger fundamentals - Investing.com
Tempus AI, Inc. $TEM Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Reiterating Buy: Tempus’s Underappreciated AI Data Advantage and Genomics Upside After a 50% Share Price Reset - TipRanks
Jefferies initiates Tempus AI stock with underperform rating - Investing.com
Jefferies initiates Tempus AI stock with underperform rating By Investing.com - Investing.com Canada
Tempus AI, Inc. $TEM Shares Sold by Baillie Gifford & Co. - MarketBeat
Jefferies initiates coverage of Tempus AI (TEM) with underperform recommendation - MSN
Tempus AI shares gain after expanded partnership with Gilead - MSN
Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration - Insider Monkey
Artificial Intelligence Stocks To Keep An Eye OnApril 12th - MarketBeat
Diversify Advisory Services LLC Has $2.86 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Does Tempus AI’s (TEM) Deeper Gilead Tie Mark a Shift in Its Platform Strategy? - simplywall.st
Artificial Intelligence Stocks To Watch NowApril 11th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
AI in Precision Medicine Market is expected to Hit US$ 16.95 - openPR.com
Tempus AI Sets $300 Million Volume Record as Gilead Deal Meets Selling Pressure - Bitget
HC Wainwright raises Tempus AI (TEM) price target to $95 - MSN
Tempus AI stock jumps, ALERT trial results boost EHR automation buzz - MSN
Best Artificial Intelligence Stocks Worth WatchingApril 10th - MarketBeat
Tempus AI stock rises on Gilead collaboration deal By Investing.com - Investing.com South Africa
Tempus AI stock rises on Gilead collaboration deal - Investing.com
Why Is Tempus AI Stock Gaining Friday?Tempus AI (NASDAQ:TEM) - Benzinga
Amazon, Snowflake, Tempus AI, Arrive AI and Eos Energy: Why these 5 stocks are on investors' radars today - MSN
Tempus AI (TEM) Stock: Gilead Partnership Deepens as Oncology Data Demand Grows - CoinCentral
Is Tempus AI (TEM) Offering A Compelling Entry Point After Recent Share Price Weakness - Yahoo Finance
AMZN, SNOW, TEM, ARAI, EOSE: 5 Trending Stocks TodayAmazon.com (NASDAQ:AMZN) - Benzinga
Tempus AI Sinks 7 Percent as $260 Million Trading Surge Signals Investor Doubt Over Gilead Deal - Bitget
Tempus AI Inc (TEM) Shares Gap Down to $45.6 on Apr 9 - GuruFocus
Why Tempus AI Stock Keeps Sliding Lower Today - TipRanks
Tempus, Median Technologies Collaborate on AI-Powered Lung Cancer Screening - Medical Product Outsourcing
Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline - Benzinga
Artificial Intelligence Stocks To Add to Your WatchlistApril 9th - MarketBeat
TEM Stock Gains 17.9% in a Year: Time to Buy, Hold or Sell? - Yahoo Finance
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE - 01net
Tempus AI expands collaboration with Gilead Sciences By Investing.com - Investing.com South Africa
Tempus AI Inc (TEM) Stock Price Quote Today & Current Price Chart - Capital.com
Tempus AI expands collaboration with Gilead Sciences - Investing.com
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.02%
1.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):